Evaluation of Immuno-oncology Treatments with Histopathology
Mike Johnson2019-09-15T19:58:51-05:00Immuno-oncology involves leveraging the power of the immune system to detect and eliminate cancer cells. Oncologists are increasingly turning [...]
Evaluating Large Molecule Pharmacokinetics: An In Vitro Approach
Mike Johnson2019-07-24T13:08:53-05:00Characterizing the transport properties of biologicals (e.g. large molecules, antibody-based therapeutics, etc.) in tissues is a complex task that, [...]
Abcam New Product Announcement – Tissue Clearing Kits
We recently announced our partnership with Abcam to launch application specific 3D imaging kits for both whole brain tissues [...]
Visikol Seminar Series
Since launching our contract research services two years ago, we have gotten a lot of questions from researchers about [...]
Digital Biotech Podcast Featuring Visikol CEO now on iTunes
Visikol CEO Dr. Michael Johnson was recently interviewed on the digital biotech podcast which is now available on itunes. [...]
Visikol Whole Rodent Brain Tissue Clearing and Imaging Services
Mike Johnson2019-07-24T10:55:15-05:00WHITEHOUSE, N.J. (PRWEB) MAY 15, 2019 The conventional method for characterizing brain tissues has always been the process of histology [...]
Blog Post: T-Cell Invasion
Mike Johnson2019-07-24T13:10:38-05:00Immuno-oncology and check point inhibitors are a part of the exploding field of modulating the body’s own immune response [...]
Featured Content: Visikol and Abcam Webinar – Understanding Tissue Clearing and Tissue Clearing Technologies
Mike Johnson2019-07-22T15:04:59-05:00We recently announced our partnership with Abcam to provide researchers with application specific 3D tissue imaging kits. These kits [...]
Visikol Awarded $750,000 in National Science Foundation Funding to Develop Novel Imaging and Machine Learning Tools
Mike Johnson2019-04-17T15:12:13-05:00WHITEHOUSE, N.J. APRIL 17, 2019 Visikol announced today that it has been awarded $750,000 in National Science Foundation SBIR Phase [...]
Literature Spotlight: Increase in resistance to anticancer drugs involves occludin in spheroid culture model of lung adenocarcinoma A549 cells
A paper published in the Open Access Journal of Scientific Reports examined the relationship between occludin expression and chemoresistance [...]